This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23; On-demand experience Delivered September 28-30Boston Convention and Exhibition Center

Eran Benjamin, Ph.D.
Global Director, QC AD at PolyPeptide Group


Eran J. Benjamin received his doctorate in Organic Chemistry with Prof. Mati Fridkin at the Weizmann Institute of Science, Israel.  Prior to joining the PolyPeptide Group in 2019 as Global Director of Quality Control and Analytical Development, Eran worked for many years with Eli Lilly and Company in the development and commercialization of Insulins and peptide-based therapeutics, and was the Director of characterization science and small molecule analytical development.

Agenda Sessions

  • ROOM 205B: Impurity Control Strategy - Liraglutide Case Study

  • Impurity Control Strategy - Liraglutide Case Study